Isabl
PrivateLast Round
Grant
Mar 8, 2024
Est. Valuation
$2.14M
Total Funding Raised
$6.22M
Company Overview
Isabl is a biotechnology company that has developed a medical diagnosis platform to analyze the entire genome and transcriptome of cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Database Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isabl Comparables
Compare Isabl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BostonGene | 77% | |
| OncoDNA | 76% | |
| GenomOncology | 75% | |
Isabl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 8, 2024 | ||||
| Seed | May 18, 2022 | ||||
| Grant | Apr 1, 2022 | ||||
| Accelerator | Apr 3, 2020 |
Isabl Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Two Sigma Ventures | Seed |
| BoxOne Ventures | Seed |
| Y Combinator | Seed, Accelerator |
| Evolution VC Partners | Seed |
| Sand Hill Angels | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2022
$3M round led by Two Sigma Ventures and Deviation Capital.
- Apr 1, 2022
$1M grant received from the National Cancer Institute.
Isabl Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Isabl's valuation, stock price, and market status.